Gelsomino F - Search Results

1

Pitfalls in Oncology: Osteoblastic Response Mimicking Bone Progression during Ceritinib Treatment in ALK-Rearranged NSCLC.

Gelsomino F, Ambrosini V, Melotti B, Sperandi F, Ardizzoni A. Gelsomino F, et al. J Thorac Oncol. 2016 Aug;11(8):e99-e101. doi: 10.1016/j.jtho.2016.04.002. Epub 2016 Apr 12. J Thorac Oncol. 2016. PMID: 27079186 Free article. No abstract available.

2

Typhlitis during second-line chemotherapy with pemetrexed in non-small cell lung cancer (NSCLC): A case report.

Tiseo M, Gelsomino F, Bartolotti M, Barili MP, Ardizzoni A. Tiseo M, et al. Among authors: gelsomino f. Lung Cancer. 2009 Aug;65(2):251-3. doi: 10.1016/j.lungcan.2009.02.021. Epub 2009 Apr 5. Lung Cancer. 2009. PMID: 19346026

3

First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype.

Tiseo M, Bartolotti M, Gelsomino F, Ardizzoni A. Tiseo M, et al. Among authors: gelsomino f. Expert Rev Anticancer Ther. 2009 Apr;9(4):425-35. doi: 10.1586/era.09.3. Expert Rev Anticancer Ther. 2009. PMID: 19374597 Review.

4

EGFR and EML4-ALK gene mutations in NSCLC: a case report of erlotinib-resistant patient with both concomitant mutations.

Tiseo M, Gelsomino F, Boggiani D, Bortesi B, Bartolotti M, Bozzetti C, Sammarelli G, Thai E, Ardizzoni A. Tiseo M, et al. Among authors: gelsomino f. Lung Cancer. 2011 Feb;71(2):241-3. doi: 10.1016/j.lungcan.2010.11.014. Epub 2010 Dec 18. Lung Cancer. 2011. PMID: 21168933

5

Accuracy of fine needle aspiration cytology in the pathological typing of non-small cell lung cancer.

Nizzoli R, Tiseo M, Gelsomino F, Bartolotti M, Majori M, Ferrari L, De Filippo M, Rindi G, Silini EM, Guazzi A, Ardizzoni A. Nizzoli R, et al. Among authors: gelsomino f. J Thorac Oncol. 2011 Mar;6(3):489-93. doi: 10.1097/JTO.0b013e31820b86cb. J Thorac Oncol. 2011. PMID: 21258246 Free article.

6

Endometrial metastasis of lung adenocarcinoma: a case report.

Tiseo M, Bersanelli M, Corradi D, Bartolotti M, Gelsomino F, Nizzoli R, Barili MP, Ardizzoni A. Tiseo M, et al. Among authors: gelsomino f. Tumori. 2011 May-Jun;97(3):411-4. doi: 10.1177/030089161109700326. Tumori. 2011. PMID: 21789025

7

Anaplastic lymphoma kinase as a new target for the treatment of non-small-cell lung cancer.

Tiseo M, Gelsomino F, Bartolotti M, Bordi P, Bersanelli M, Rossi G, Ardizzoni A. Tiseo M, et al. Among authors: gelsomino f. Expert Rev Anticancer Ther. 2011 Nov;11(11):1677-87. doi: 10.1586/era.11.157. Expert Rev Anticancer Ther. 2011. PMID: 22050016 Review.

8

Asymptomatic pulmonary embolism in lung cancer: prevalence and analysis of clinical and radiological characteristics in 141 outpatients.

Tiseo M, Bersanelli M, Pesenti Barili M, Bartolotti M, De Luca G, Gelsomino F, Camisa R, Cademartiri F, Ardizzoni A. Tiseo M, et al. Among authors: gelsomino f. Tumori. 2012 Sep-Oct;98(5):594-600. doi: 10.1177/030089161209800509. Tumori. 2012. PMID: 23235754

9

MET and ALK as targets for the treatment of NSCLC.

Capelletti M, Gelsomino F, Tiseo M. Capelletti M, et al. Among authors: gelsomino f. Curr Pharm Des. 2014;20(24):3914-32. doi: 10.2174/13816128113196660760. Curr Pharm Des. 2014. PMID: 24138716 Review.

10

Correlation between erlotinib pharmacokinetics, cutaneous toxicity and clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC).

Tiseo M, Andreoli R, Gelsomino F, Mozzoni P, Azzoni C, Bartolotti M, Bortesi B, Goldoni M, Silini EM, De Palma G, Mutti A, Ardizzoni A. Tiseo M, et al. Among authors: gelsomino f. Lung Cancer. 2014 Feb;83(2):265-71. doi: 10.1016/j.lungcan.2013.12.001. Epub 2013 Dec 12. Lung Cancer. 2014. PMID: 24388705

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters